Clinical Trial Update: Vorinostat and IV Fluorouracil/Leucovorin (5FU/LV) in Patients With Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating Vorinostat in combination with intravenous fluorouracil/leucovorin for metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• Vorinostat (vorinostat)

Snippet

Sponsor: University of Southern California | Conditions: Colorectal Cancer | Phase 1 | Status: COMPLETED